Stenocare A/S
NASDAQ CopenhagenTotal Valuation
Stenocare A/S carries a market capitalization of 44.49M, placing it among publicly traded companies globally. Its enterprise value stands at 17.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 44.49M |
| Enterprise Value | 17.74M |
Share Statistics
Stenocare A/S currently has 38.20M shares outstanding.
| Shares Outstanding | 38.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 6.98, and the price-to-book ratio stands at 8.65.
| PE Ratio | N/A |
| PS Ratio | 6.98 |
| PB Ratio | 8.65 |
| P/TBV Ratio | 8.65 |
| P/FCF Ratio | -3.67 |
| P/OCF Ratio | -3.67 |
Enterprise Valuation
| EV / Sales | 6.26 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Stenocare A/S maintains a current ratio of 1.64, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.97, indicating elevated leverage, while an interest coverage ratio of -16.90 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.64 |
| Quick Ratio | 0.94 |
| Debt / Equity | 123.97 |
| Debt / EBITDA | -0.19 |
| Interest Coverage | -16.90 |
Financial Efficiency
| Return on Equity (ROE) | -281.87 |
| Return on Assets (ROA) | -164.84 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 391,671.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Stenocare A/S's stock has gained approximately 119.14894% over the past 52 weeks. The 50-day moving average sits at 1.11, while the 200-day moving average is 1.34.
| Beta (5Y) | N/A |
| 52-Week Price Change | 119.14894% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.34 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Stenocare A/S generated 2.83M in revenue and converted that into -29.17M in net income, yielding earnings per share of -0.80. EBITDA reached -14.94M, while operating income came in at -14.94M.
| Revenue | 2.83M |
| Gross Profit | N/A |
| Operating Income | -14.94M |
| Pretax Income | -28.78M |
| Net Income | -29.17M |
| EBITDA | -14.94M |
| EBIT | -14.94M |
| Earnings Per Share (EPS) | -0.80 |
Balance Sheet
Stenocare A/S holds 4.87M in cash and equivalents against 2.83M in total debt, resulting in a net debt position of -2.07M. Total book value stands at 2.29M, with working capital of 3.33M providing operational flexibility.
| Cash & Cash Equivalents | 4.87M |
| Total Debt | 2.83M |
| Net Debt | -2.07M |
| Equity (Book Value) | 2.29M |
| Book Value Per Share | 0.06 |
| Working Capital | 3.33M |
Cash Flow
Stenocare A/S produced -5.39M in operating cash flow over the past twelve months.
| Operating Cash Flow | -5.39M |
| Capital Expenditures | N/A |
| Free Cash Flow | -5.39M |
| FCF Per Share | -0.15 |
Margins
Stenocare A/S operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -527.28 and net profit margin of -1,029.89 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -527.28 |
| Pretax Margin | -1,016.07 |
| Profit Margin | -1,029.89 |
| EBITDA Margin | -527.28 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -48.73 |
| FCF Yield | -27.24 |
Stock Splits
Stenocare A/S's most recent stock split took place on May 22, 2023 with a 1000:1059 split ratio.
| Last Split Date | 5/22/2023 |
| Split Ratio | 1000:1059 |
Scores
Stenocare A/S posts an Altman Z-Score of -3.19, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.19 |